# Catheter Ablation for Atrial Fibrillation in patientS With End-sTage Heart Failure and Eligibility for Heart Transplantation

> **NCT04649801** · NA · COMPLETED · sponsor: **Heart and Diabetes Center North-Rhine Westfalia** · enrollment: 194 (actual)

## Conditions studied

- Heart Failure
- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Atrial fibrillation ablation

## Key facts

- **NCT ID:** NCT04649801
- **Lead sponsor:** Heart and Diabetes Center North-Rhine Westfalia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-05-15
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2023-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04649801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04649801, "Catheter Ablation for Atrial Fibrillation in patientS With End-sTage Heart Failure and Eligibility for Heart Transplantation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04649801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*